News » AIDS

NMAC's 2nd Annual Biomedical HIV Prevention Summit Hits New Orleans

Monday Dec 4, 2017

The annual Biomedical HIV Prevention Summit, organized by NMAC, opens today in New Orleans and runs through December 5th. The Summit brings together community leaders, care providers, and HIV advocates to learn the latest information and best practices to use biomedical HIV prevention tools like Treatment as Prevention (TasP) and Pre-Exposure Prophylaxis (PrEP) more effectively. For a full program of USCA events, activities, and speakers, visit the Summit website.

"NMAC started the Summit as a way to bring more attention to biomedical methods of HIV prevention and to share information and best practices on how to use them," said NMAC Executive Director Paul Kawata. "Areas that have readily adopted them have started to see significant reductions in new HIV diagnoses. However, we still see great racial disparities in which communities are using tools like PrEP. Since communities of color are disproportionately affected by HIV, we must ensure that those communities have access to these tools and use them."

The Summit is supported by Presenting Sponsor Gilead; Champion Sponsor ViiV Healthcare; Benefactor Sponsors Janssen and Houston Health Department; Supporters Texas Health Action-Kind Clinic, Walgreen's, and Washington State Department of Health; and Ally Sponsors Avita Pharmacy and Planned Parenthood.

NMAC leads with the race to urgently fight for health equity and racial justice to end the HIV epidemic in America. Since 1987, NMAC has advanced our mission through a variety of programs and services, including a public policy education program, national and regional training conferences, a treatment and research program, numerous electronic and print materials, and a website. NMAC also serves as an association of AIDS service organizations, providing valuable information to community-based organizations, hospitals, clinics, and other groups assisting individuals and families affected by the HIV epidemic.

For more information, visit


Add New Comment

Comments on Facebook